Product information
From Health Canada
The product monograph is developed by a drug sponsor according to guidelines published by Health Canada that provide direction on the content and format. The veterinary labelling is developed by the drug sponsor according to the Food and Drug Regulations. While Health Canada reviews the product monograph or the veterinary labelling as part of the drug review process, it remains the responsibility of the drug sponsor to ensure that the product monograph or the veterinary labelling is complete and accurate.
Current status:
Approved
Current status date:
2020-02-21
Product name:
ASN-CEPHALEXIN
DIN:
02496445
Product Monograph/Veterinary Labelling:
Date:
2021-01-06
Product monograph/Veterinary Labelling (PDF version ~ 175K)
Company:
ASCEND LABORATORIES LTD
4 Robert Speck Parkway, 15th Floor
Mississauga
Ontario
Canada
L4Z 1S1
Class:
Human
Dosage form(s):
Powder For Suspension
Route(s) of administration:
Oral
Number of active ingredient(s):
1
Schedule(s):
Prescription
American Hospital Formulary Service (AHFS): See footnote 3
08:12.06.04
Anatomical Therapeutic Chemical (ATC): See footnote 4
J01DB01 CEFALEXIN
Active ingredient group (AIG) number:See footnote5
0105911001
| Active ingredient(s) See footnote8 | Strength |
|---|---|
| CEPHALEXIN (CEPHALEXIN MONOHYDRATE) | 125 MG / 5 ML |